IRVINE, Calif.–(BUSINESS WIRE)–Dec. 18, 2015–
Masimo
(NASDAQ: MASI), the global innovator of noninvasive patient monitoring
technologies, announced today that it will increase investment in
infrastructure and research and development in response to the
moratorium on the Medical Device Tax.

For years, the United States has led the world in life-saving medical
innovations. Unfortunately, the Medical Device Tax of 2013 became an
impediment to innovation that springs from start-ups, and many
established companies curtailed their investments in research and
development and reduced their workforces to pay the new reve…

Más información: Masimo Pledges to Increase Investment in Research & Development and Infrastructure, in Response to Today’s Moratorium on the Medical Device Tax